89bio Q3 EPS $(0.45) Beats $(0.53) Estimate
Portfolio Pulse from Benzinga Newsdesk
89bio (NASDAQ:ETNB) reported Q3 losses of $(0.45) per share, beating the analyst consensus estimate of $(0.53) by 15.09 percent. This represents a 21.05 percent increase over losses of $(0.57) per share from the same period last year.
November 08, 2023 | 9:56 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
89bio's Q3 earnings beat analyst estimates by 15.09%, showing a 21.05% improvement from last year's Q3.
89bio's Q3 earnings beat analyst estimates, which is generally seen as a positive sign by investors. This could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100